Darlene Noci
Corporate Officer/Principal chez NUVALENT, INC.
Fortune : 3 M $ au 31/03/2024
Profil
Darlene Noci is the founder of Noci Strategic Consulting LLC, which was founded in 2018.
Currently, Ms. Noci is the Chief Development Officer at Nuvalent, Inc. since 2022.
Previously, Ms. Noci held the position of Head-Regulatory Affairs at AVEO Pharmaceuticals, Inc. Ms. Noci also served as the VP-Regulatory Affairs & Quality Assurance at X4 Pharmaceuticals, Inc. from 2016 to 2018, and as a Principal at EMD Serono, Inc. from 2014 to 2016.
Ms. Noci obtained a graduate degree from Harvard University and an undergraduate degree from Adelphi University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUVALENT, INC. CLASS A
0,06% | 22/03/2024 | 33 300 ( 0,06% ) | 3 M $ | 31/03/2024 |
Postes actifs de Darlene Noci
| Sociétés | Poste | Début |
|---|---|---|
| NUVALENT, INC. | Corporate Officer/Principal | 20/07/2022 |
Anciens postes connus de Darlene Noci
| Sociétés | Poste | Fin |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | General Counsel | 01/05/2018 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01/01/2016 |
| Noci Strategic Consulting LLC | Founder | - |
| AVEO PHARMACEUTICALS, INC. | General Counsel | - |
Formation de Darlene Noci
| Harvard University | Graduate Degree |
| Adelphi University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| X4 PHARMACEUTICALS, INC. | Health Technology |
| NUVALENT, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Noci Strategic Consulting LLC |
